Workflow
汇添富基金管理股份有限公司
icon
Search documents
8月1日港股通消费50ETF(159268)份额增加100.00万份,最新份额1.40亿份,最新规模1.37亿元
Xin Lang Cai Jing· 2025-08-04 01:12
8月1日,港股通消费50ETF(159268)跌0.70%,成交额1434.92万元。当日份额增加100.00万份,最新 份额为1.40亿份。最新资产净值计算值为1.37亿元。 港股通消费50ETF(159268)业绩比较基准为国证港股通消费主题指数收益率(经估值汇率调整后),管 理人为汇添富基金管理股份有限公司,基金经理为乐无穹,成立(2025-07-10)以来回报为-2.17%。 来源:新浪基金∞工作室 风险提示:市场有风险,投资需谨慎。本文为AI大模型自动发布,任何在本文出现的信息(包括但不 限于个股、评论、预测、图表、指标、理论、任何形式的表述等)均只作为参考,不构成个人投资建 议。 ...
7月新发数量创今年新高 权益类基金发行大幅回暖
Group 1 - In July, the public fund issuance saw a resurgence with nearly 150 new funds launched, marking a monthly issuance record for the year [1] - The strong market performance has led to increased investor sentiment, making it easier for fund companies to issue new products [1] - The optimism from fund companies regarding future market performance is reflected in the high issuance enthusiasm [1] Group 2 - As of August 3, over 90 of the 149 newly launched public funds in July have been established, with total fund issuance exceeding 800 billion units [2] - Bond funds dominated the issuance scale, accounting for more than half of the total, with the largest single product being Huatai-PineBridge's 6-month holding fund, which issued 3.741 billion units [2] - The first batch of Sci-Tech Bond ETFs was a highlight, with 10 ETFs collectively issuing over 28 billion units, representing nearly 40% of the total issuance for July [2] Group 3 - Equity fund issuance showed significant recovery, with 81 new stock funds launched in July, nearly 2.8 times that of the same period last year [3] - The issuance scale of stock funds in July was 5.7 times higher than last year, with stock funds accounting for 32.33% of total fund issuance [3] - The total issuance of stock funds in the first seven months of the year exceeded 210 billion, reflecting substantial growth compared to the previous year [3] Group 4 - Looking ahead, the issuance of equity funds is expected to continue to rise, supported by favorable market conditions and policies [4] - Over 60 public funds are scheduled to launch in August, with more than 80% being equity funds [4] - On August 4, 18 equity funds were launched, primarily consisting of actively managed funds [4] Group 5 - A second batch of 12 new floating fee rate products has been approved, including 2 stock funds and 10 mixed equity funds [5] - The new floating fee rate products are expected to align the interests of fund managers and investors, promoting healthy industry development [5] - The regulatory framework encourages leading fund management firms to issue floating fee rate funds, aiming for at least 60% of their active equity fund issuance [5]
海外布局动作频频公募国际化进程持续推进
Group 1: Institutional Movements - The internationalization process of public funds is continuously advancing, with institutions frequently "going abroad" [1][2] - On July 30, Rongtong Fund's subsidiary successfully launched its first public fund product in Hong Kong, providing overseas investors with more channels to invest in Chinese assets [1][2] - The China Securities Regulatory Commission (CSRC) has approved the establishment of a subsidiary in Singapore by Xingzheng Global Fund, indicating a gradual expansion of overseas business capabilities [2][3] Group 2: Acceleration of Public Fund Internationalization - The CSRC has issued guidelines to enhance the supervision of securities companies and public funds, promoting high-level openness and supporting qualified foreign institutions to establish operations in China [3] - The public fund industry is expected to take on greater responsibilities and promote representative quality indices to overseas markets [3] Group 3: ETFs Entering Overseas Markets - Multiple ETFs have been launched in overseas markets this year, including the launch of the Aoming E Fund ChiNext ETF in Singapore on July 22 [4] - The first ETF tracking the China Securities Index Dividend Index was successfully listed in Singapore in March, marking a significant step in cross-border investment tools [4] - Several ETFs have also been listed in Brazil, facilitating easier access for Brazilian investors to invest in the Chinese market [4][5]
8月1日汇添富沪深300安中指数A净值下跌0.78%,今年来累计上涨3.61%
Sou Hu Cai Jing· 2025-08-01 12:36
Group 1 - The core point of the article highlights the performance and holdings of the Huatai-PineBridge CSI 300 Anzhong Index A fund, which has a recent net value of 1.9429 yuan and a decline of 0.78% [1] - The fund's one-month return is 4.19%, ranking 724 out of 1620 in its category, while the three-month return is 8.95%, ranking 883 out of 1541 [1] - Year-to-date, the fund has achieved a return of 3.61%, with a ranking of 1108 out of 1423 in its category [1] Group 2 - The top ten stock holdings of the fund account for a total of 22.91%, with significant positions in companies such as China Shenhua (3.43%), China Yangtze Power (3.09%), and Kweichow Moutai (2.90%) [1] - As of June 30, 2025, the fund has a total size of 1.375 billion yuan, and the fund manager is Wu Zhenxiang [1] Group 3 - Wu Zhenxiang has a strong academic background with a PhD in management from the University of Science and Technology of China and a postdoctoral degree in applied mathematics from the Chinese Academy of Sciences [2] - He has extensive experience in fund management, having held various positions at Huatai-PineBridge since March 2008, including senior manager and quantitative investment analyst [2]
汇添富恒生科技ETF联接发起式(QDII)C连续5个交易日下跌,区间累计跌幅4.12%
Sou Hu Cai Jing· 2025-07-30 16:30
截止2025年6月30日,汇添富恒生科技ETF联接发起式(QDII)C前三持仓占比合计1.45%,分别为:25国 债08(0.80%)、24国债15(0.54%)、24国债21(0.11%)。 来源:金融界 7月30日,汇添富恒生科技ETF联接发起式(QDII)C(013128)下跌2.58%,最新净值0.89元,连续5个交 易日下跌,区间累计跌幅4.12%。 据了解,汇添富恒生科技ETF联接发起式(QDII)C成立于2021年10月,基金规模11.08亿元,成立来累计 收益率-10.64%。从持有人结构来看,截至2024年末,汇添富恒生科技ETF联接发起式(QDII)C的基金机 构持有0.01亿份,占总份额的0.20%,个人投资者持有7.32亿份,占总份额的99.80%。 公开信息显示,现任基金经理乐无穹女士:中国国籍,复旦大学经济学硕士。从业资格:证券投资基金从业 资格。2014年7月加入汇添富基金管理股份有限公司,历任金融工程助理分析师、指数与量化投资部分析 师。2019年4月15日至2023年8月29日任中证银行交易型开放式指数证券投资基金联接基金的基金经理。 2019年7月26日至2024年04月1 ...
汇添富恒生科技ETF联接发起式(QDII)A连续5个交易日下跌,区间累计跌幅4.12%
Sou Hu Cai Jing· 2025-07-30 16:30
截止2025年6月30日,汇添富恒生科技ETF联接发起式(QDII)A前三持仓占比合计1.45%,分别为:25国 债08(0.80%)、24国债15(0.54%)、24国债21(0.11%)。 来源:金融界 7月30日,汇添富恒生科技ETF联接发起式(QDII)A(013127)下跌2.59%,最新净值0.9元,连续5个交 易日下跌,区间累计跌幅4.12%。 据了解,汇添富恒生科技ETF联接发起式(QDII)A成立于2021年10月,基金规模7.74亿元,成立来累计 收益率-9.90%。从持有人结构来看,截至2024年末,汇添富恒生科技ETF联接发起式(QDII)A的基金机 构持有0.14亿份,占总份额的2.15%,个人投资者持有6.27亿份,占总份额的97.85%。 公开信息显示,现任基金经理乐无穹女士:中国国籍,复旦大学经济学硕士。从业资格:证券投资基金从业 资格。2014年7月加入汇添富基金管理股份有限公司,历任金融工程助理分析师、指数与量化投资部分析 师。2019年4月15日至2023年8月29日任中证银行交易型开放式指数证券投资基金联接基金的基金经理。 2019年7月26日至2024年04月19日任 ...
年内最强基金“闭门谢客”
Guo Ji Jin Rong Bao· 2025-07-30 15:52
Core Viewpoint - The recent surge in the Hong Kong stock market has led several QDII funds, including the top-performing Huatai-PineBridge Hong Kong Advantage Select, to suspend subscriptions to protect the interests of existing investors [1][4][11]. Group 1: Fund Performance and Actions - Huatai-PineBridge Hong Kong Advantage Select (QDII) reported a year-to-date net value increase of 139.12% as of July 28, making it the top fund in the market [1][6]. - Multiple QDII funds have announced restrictions or suspensions on subscriptions and regular investments, including those tracking European and Japanese markets, to ensure stable operations and protect investor interests [3][4]. - The suspension of subscriptions is attributed to excessive investor enthusiasm, leading to tight foreign exchange quotas [1][6][11]. Group 2: Market Trends and Investor Behavior - The QDII fund sector has seen a significant increase in total scale, reaching 683.77 billion yuan by the end of June, up from 611.32 billion yuan at the end of last year, despite a slight decrease in the number of funds [9]. - The inflow of funds into cross-border ETFs, particularly those related to Hong Kong stocks, has been notable, with significant net inflows recorded for various ETFs [10]. - The current market environment is characterized by a "barbell strategy," where investors are allocating funds to both dividend stocks and growth stocks, influenced by liquidity conditions and risk preferences [10].
重磅会议召开!这些基金年内涨超100%!
天天基金网· 2025-07-30 11:30
Core Viewpoint - The article discusses the recent performance of the A-share market, highlighting a recovery in the Shanghai Composite Index after a political bureau meeting that released positive signals for the economy and investment opportunities in the innovative pharmaceutical sector [1][2][8]. Group 1: A-share Market Performance - The A-share market experienced a pullback but rebounded in the afternoon, with the Shanghai Composite Index closing in the green, reaching a new high for the year [2][7]. - The market showed significant structural differentiation, with consumer and banking sectors rising while technology and new energy sectors faced declines [6][7]. - The trading volume exceeded 1.84 trillion yuan, indicating active market participation [5]. Group 2: Political Bureau Meeting Insights - The Central Political Bureau meeting emphasized the need to "stably resolve local government debt risks" and introduced a roadmap for "clearing financing platforms," alleviating systemic risk concerns [9]. - The meeting also highlighted the importance of stimulating domestic demand and implementing actions to boost consumption, positively impacting sectors like tourism, retail, and food and beverage [10]. - A focus on technological innovation was reiterated, aiming to foster new competitive industries and integrate technological advancements with industrial development [12]. Group 3: Investment Opportunities in Innovative Pharmaceuticals - A significant number of funds have achieved over 100% returns this year, particularly in the innovative pharmaceutical sector, with several funds listed showing substantial year-to-date performance [17]. - Fund managers suggest a cautious yet optimistic approach to the innovative pharmaceutical sector, advising investors to match risk and return expectations and avoid excessive chasing of high-flying stocks [18][19]. - Key guidelines for selecting funds include focusing on long-term performance stability, understanding investment strategies, and aligning with personal risk preferences [20].
数十家券商火速开通交易权限,科创成长层来了;7月基金发行超900亿份 | 券商基金早参
Mei Ri Jing Ji Xin Wen· 2025-07-30 01:08
Group 1 - Several securities firms, including CITIC Securities and Guosen Securities, have quickly launched trading permissions for the new Sci-Tech Growth Board, indicating high market interest in this new segment [1] - Investors need to meet a threshold of 500,000 yuan in assets and have two years of investment experience to participate, which helps filter qualified investors and manage risks [1] - The introduction of the Sci-Tech Growth Board enhances the multi-tiered capital market structure, providing financing channels for tech innovation companies, which is expected to boost overall market vitality and innovation momentum in the long term [1] Group 2 - On July 29, Founder Securities announced that its major shareholder, China Cinda Asset Management, did not execute its planned share reduction, which is seen as a positive signal for the company's long-term value [2] - The unchanged shareholding of China Cinda, which holds 593 million shares (7.2% of total shares), may help stabilize market sentiment and alleviate investor concerns about share dilution [2] - This situation is likely to support the brokerage sector and enhance confidence in financial stocks, contributing to market stability [2] Group 3 - In July, over 900 billion yuan worth of new funds were issued, indicating a recovery in market confidence [3] - The increase in stock and bond fund shares, driven by the equity market and innovative products like the Sci-Tech Bond ETF, reflects a growing risk appetite among investors [3] - The decline in mixed fund shares suggests a preference for clearer directional investments, which may lead to increased activity in related sectors and improved market liquidity [3] Group 4 - Seven ETFs have achieved "doubling" performance this year, with the top performer, Huatai-PB Hang Seng Innovation Drug ETF, showing a 107.67% return [4] - The strong performance of Hong Kong innovation drug ETFs highlights the robust market interest in the innovative drug sector, potentially attracting more capital into the healthcare segment [4] - Continued advancements in innovative drug research and supportive policies are key drivers for the pharmaceutical industry, with high-performing ETFs likely to enhance investor risk appetite [4]
兰生股份连跌5天,汇添富基金旗下1只基金位列前十大股东
Sou Hu Cai Jing· 2025-07-29 14:46
Company Overview - Lansheng Co., Ltd. has experienced a decline in stock price, with a cumulative drop of -24.79% over five consecutive trading days [1] - The company is a comprehensive state-owned listed entity under Donghao Lansheng Group, which is among China's top 500 enterprises [1] Financial Performance - The report indicates that Huatai-PB Fund's Huatai-PB CSI Shanghai State-owned Enterprises ETF reduced its holdings in Lansheng Co., Ltd. during the first quarter of this year [1] - The fund has achieved a year-to-date return of 3.36%, ranking 3033 out of 3393 in its category [1] Fund Manager Profile - The fund manager of Huatai-PB CSI Shanghai State-owned Enterprises ETF is Wu Zhenxiang, who holds a Ph.D. in Management from the University of Science and Technology of China [3] - Wu Zhenxiang has extensive experience in fund management, having held various positions since joining Huatai-PB Fund in March 2008 [3][4]